Active Biotech AB (ACTI) Stock Statistics & Valuation Metrics

Active Biotech AB has a market cap or net worth of €107.02M. The enterprise value is kr40.68M.

Active Biotech AB has 1,230,164,700 shares outstanding. The number of shares has decreased by -2.65% in one year.

Active Biotech AB’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Active Biotech AB is -1.16. Active Biotech AB’s PEG ratio is 0.03.

In the last 12 months, Active Biotech AB had revenue of 0.00 and earned -39.40M in profits. Earnings per share was -0.09.

In the last 12 months, operating cash flow was -40.40M and capital expenditures 0.00, giving a free cash flow of -40.40M billion.

Active Biotech AB pays an annual dividend of ―, resulting in a dividend yield of ―

Active Biotech AB upcoming earnings date is May 8, 2025, TBA Not Confirmed.

Active Biotech AB as a current ratio of 4.40, with Debt / Equity ratio of 0.00%

In the past 12 months, Active Biotech AB has paid 0.00 in taxes.

Active Biotech AB EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Active Biotech AB has €27.40M in cash and marketable securities with kr0.00 in debt, giving a net cash position of -€27.40M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Active Biotech AB is ―, which is 11.43% higher than the current price. The consensus rating is ―